Proterro - About the company
Proterro is a series A company based in Bronxville (United States), founded by John Aikens. It operates as a Developer of biotechnology platforms utilizing cyanobacteria to create industrial products. Proterro has raised $8.5M in funding from Braemar Energy Ventures. The company has 2069 active competitors, including 454 funded and 323 that have exited. Its top competitors include companies like Antheia, Synthego and Axol Bioscience.
Company Details
Developer of biotechnology platforms utilizing cyanobacteria to create industrial products. This technology platform employs modified organisms within solid state bioreactors to convert carbon dioxide into chemical components. These systems support the production of materials for the food, animal feed, and energy sectors. The process integrates into existing production environments through modular, scalable configurations designed for output efficiency.
- Website
- proterro.com
- Social
- Email ID
- *****@proterro.com
Key Metrics
Location
Bronxville, United States
Stage
Series A
Total Funding
$8.5M in 2 rounds
Latest Funding Round
Investors
Ranked
838th among 2069 active competitors
Employee Count
1 as on Jul 01, 2024
Sign up to download Proterro's company profile
Proterro's funding and investors
Proterro has raised a total funding of $8.5M over 2 rounds. Its first funding round was on Nov 18, 2010. Its latest funding round was a Series A round on Dec 17, 2012 for $*****. 5 investors participated in its latest round. Proterro has 6 institutional investors.
Here is the list of recent funding rounds of Proterro:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 17, 2012 | 5648523 | Series A | 6765167 | 9896790 | 5829993 | 5183374 |
Nov 18, 2010 | 3012817 | Series A | 6314698 | 5863968 | 5203291 |
Access funding benchmarks and valuations. Sign up today!View details of Proterro's funding rounds and investors
Proterro's founders and board of directors
Founder? Claim ProfileThe founders of Proterro is John Aikens.
Here are the details of Proterro's key team members:
- John Aikens: Founder & CTO of Proterro.
- Colin South: CEO of Proterro.
View details of Proterro's Founder profiles and Board Members
Proterro's employee count trend
Proterro has 1 employees as of Jul 24. Here is Proterro's employee count trend over the years:
Uncover Proterro's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Proterro's Competitors and alternates
Top competitors of Proterro include Antheia, Synthego and Axol Bioscience. Here is the list of Top 10 competitors of Proterro, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 68/100 | |
2nd | Synthego 2012, Redwood City (United States), Acquired | Manufacturer of custom CRISPR gene editors and molecular biology reagents | $460M | 67/100 | |
3rd | Axol Bioscience 2013, Cambridge (United Kingdom), Series A | Provider of human cells, reagents, and reprogramming services | $13.3M | 65/100 | |
4th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
5th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 65/100 | |
6th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 64/100 | |
7th | Avalyn Pharma 2011, Seattle (United States), Public | Developer of therapies for the treatment of Idiopathic Pulmonary Fibrosis | $389M | 64/100 | |
8th | Developer of oral non-viral gene therapy platform | $54M | 63/100 | ||
9th | _1576054856947.png?devicePixelRatio=2&height=30&width=30){kind=logo} Watchmaker Genomics 2018, Boulder (United States), Series A | Developer of gene-editing technology | $48.3M | 63/100 | |
10th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 63/100 | |
838th | Proterro Bronxville (United States), Series A | Developer of biotechnology platforms utilizing cyanobacteria to create industrial products | $8.5M | 28/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Proterro's competitors? Click here to see the top ones
Proterro's Investments and acquisitions
Proterro has made no investments or acquisitions yet.
Reports related to Proterro
Here is the latest report on Proterro's sector:
News related to Proterro
•
Proterro Secures $3.5 Million in New Funding To Advance Development of Its Non-crop-based, Noncellulosic Sucrose for Biofuels and Biobased ChemicalsBusiness Wire•Dec 17, 2012•Proterro, Braemar Energy Ventures, Battelle Ventures, Middleland Capital and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Proterro
Explore our recently published companies
- Karyan Infracom - Delhi based, 2016 founded, Unfunded company
- RIS Management - Kolkata based, 2009 founded, Public company
- Elcon Drugs & Formulations - Jaipur based, 1972 founded, Unfunded company
- Gokhru - Indore based, 2023 founded, Unfunded company
- Balaji Engineers & Consultants - India - Gurugram based, 2010 founded, Unfunded company
- Open Faves - Unfunded company
